SDSignal Desk

Google DeepMind, Meta and Isomorphic put $300 million into Biohub’s $1.8 billion virtual-cell data push

· Updated · Signal Desk newsroom

Analysis of reporting by The Verge. How we work

Image: The Verge

Rival AI developers are jointly funding Biohub, the Chan Zuckerberg nonprofit, as part of a $1.8 billion effort to build AI-ready biological datasets, alongside more than $500 million from the Department of Energy and NIH data resources. Access terms remain unclear.

Key takeaways

  • Google DeepMind, Meta and Isomorphic Labs are contributing a combined $300 million, per Reuters.
  • The money is part of a $1.8 billion effort to build AI-ready biological datasets.
  • The Department of Energy plans to invest more than $500 million over five years.
  • NIH is contributing datasets and repositories from more than $500 million in earlier federal investment.
  • The goal is a “virtual cell” for simulating experiments before lab work.

The commitments

The Verge, citing Reuters, reports that Google DeepMind, Meta and AI drug discovery startup Isomorphic Labs are putting a combined $300 million into Biohub, the biomedical research nonprofit founded in 2016 by Mark Zuckerberg and Priscilla Chan. The money is part of a $1.8 billion effort to build AI-ready biological datasets.

The public side is notable too. The Department of Energy plans to invest more than $500 million over five years, and the National Institutes of Health is contributing datasets, repositories and knowledge bases that came out of earlier federal investment totaling more than $500 million. Biohub has framed the virtual cell, a model researchers can use to run biological simulations, as central to its mission since its founding.

Why shared data

Companies that compete on models agreeing to fund the same data suggests that in biology the scarce input is large, consistent, well-labeled measurements of how cells behave rather than clever architectures. Biohub’s head of science, Alex Rives, frames it as work requiring coordinated data generation at national and international scale. Doing that once in a shared effort avoids duplicating it behind several corporate walls.

If it works, a predictive cell model could let scientists screen ideas digitally, discard dead ends faster and direct scarce lab time toward experiments most likely to matter for preventing and managing disease. Google has pursued other AI-for-health research, such as its AMIE clinical system (AMIE).

Caveats and governance

A virtual cell is a goal, not a product. No one has shown a simulation can substitute for wet-lab biology, and if “the model predicted it” begins standing in for evidence in grant reviews, drug development or clinical arguments, that would be a misuse. Predictions should narrow the search rather than end it, and patients will see any payoff only after years of validation.

Governance is the bigger open question. Public agencies are contributing hundreds of millions of dollars and years of taxpayer-funded data, alongside three powerful AI companies. The reporting does not specify who can access the resulting datasets, on what terms, or whether funders receive privileged use. Those details will determine whether the project becomes a public scientific commons or a subsidized training set for a few labs. More in our Google coverage, Meta coverage, healthcare coverage and research coverage.

Who feels it

Biomedical researchers
Large shared datasets could make computational experiments more credible.
AI labs
A stake in foundational biology data without building it alone.
Taxpayers and agencies
DOE money and NIH data make access terms a public-interest issue.
Patients
Faster hypotheses are not the same as faster treatments.

What to watch

  1. Published access and licensing terms.
  2. Any early or exclusive funder access.
  3. Peer-reviewed virtual-cell predictions confirmed in the lab.
  4. New partners joining the $1.8 billion initiative.

FAQ

Who is funding Biohub?

Google DeepMind, Meta and Isomorphic Labs ($300 million combined), plus DOE and NIH resources.

What is a virtual cell?

A model that lets researchers simulate biological experiments before lab work.

How big is the overall effort?

$1.8 billion to build AI-ready biological datasets.

What is unresolved?

Who can access the datasets and whether funders get privileged use.

Read the original

Continue at the source.

The Verge

Companies: Google, Meta

More on Google

All Google coverage →